Full-Time

AI Fellow

Humana

Humana

10,001+ employees

Medicare Advantage health insurer for seniors

Compensation Overview

$208.5k - $286.7k/yr

+ Bonus

Louisville, KY, USA

In Person

Category
AI & Machine Learning
Required Skills
LLM
Streamlit
MLOps
Microsoft Azure
TensorFlow
PyTorch
Machine Learning
OpenAI
Data Engineering
RAG
AWS
Google Cloud Platform

Get referred to Humana

See people who can refer or advise you

Requirements
  • 10+ years of experience in artificial intelligence, machine learning, advanced analytics, or enterprise technology strategy, with increasing technical depth.
  • Experience shaping or advising on enterprise-scale artificial intelligence platforms, architectures, or transformations.
  • Experience influencing C-level and senior executives on complex technical and strategic topics.
  • Experience working in highly matrixed Fortune 100 environments or equivalent scale.
  • Experience personally building prototypes or proof-of-concepts that influenced strategic or investment decisions at the enterprise level.
  • Experience presenting to C-suite, board, or equivalent audiences through executive storytelling and strategic communication.
  • Experience translating external industry trends into internal strategy adjustments or new capability investments.
  • Deep understanding of the machine learning lifecycle and machine learning operations.
  • Deep understanding of generative artificial intelligence and large language model ecosystems.
  • Deep understanding of data architectures and cloud platforms such as Azure, Amazon Web Services, or Google Cloud Platform.
  • Hands-on familiarity with model development frameworks such as PyTorch and TensorFlow.
  • Hands-on familiarity with large language model orchestration frameworks and tooling.
  • Hands-on familiarity with vector databases, embeddings, and retrieval architectures.
  • Hands-on familiarity with rapid prototyping tools and environments such as Jupyter notebooks, Streamlit, and Gradio.
  • Hands-on familiarity with application programming interface-first experimentation with large language model providers such as OpenAI, Anthropic, and open-source models.
  • Hands-on familiarity with low-code/no-code artificial intelligence platforms for fast demonstration builds.
  • Strong grasp of system design, scalability, and distributed architectures.
  • Strong written and verbal communication skills for crafting narratives across technical and non-technical audiences.
  • Strong visual communication and data storytelling capabilities.
  • Ability to operate with influence and credibility in highly matrixed environments without positional authority.
Responsibilities
  • Lead the development and evolution of the multi-year enterprise artificial intelligence strategy, including generative artificial intelligence, machine learning, and emerging artificial intelligence paradigms.
  • Own the articulation and maintenance of the multi-year enterprise artificial intelligence roadmap as it evolves with business priorities, technology maturity, and competitive landscape shifts.
  • Serve as the primary architect of Humana's artificial intelligence strategy, defining necessary technology investments and driving transparency in prioritization and planning.
  • Develop and maintain a capability-to-outcome mapping framework connecting foundational artificial intelligence platform capabilities, including model orchestration, data pipelines, and machine learning operations, to prioritized business use cases and measurable outcomes.
  • Provide domain expertise on ecosystem design and integration patterns across enterprise systems, and partner with artificial intelligence platform engineering on scaled capabilities.
  • Shape reference architectures and scalable platform models that enable reuse, interoperability, and rapid experimentation.
  • Advise on large language model strategy, including model selection, orchestration approaches, retrieval-augmented generation architectures, and optimization techniques.
  • Personally build and lead rapid prototypes and proof-of-concepts demonstrating the feasibility and business value of emerging artificial intelligence capabilities.
  • Establish lightweight frameworks for fast experimentation, learning, and iteration across the artificial intelligence organization.
  • Translate strategic concepts into working demonstrations that accelerate stakeholder alignment and de-risk enterprise-scale investments.
  • Use modern artificial intelligence tooling, including large language model application programming interfaces, orchestration frameworks, and low-code/no-code platforms, to advise on implementation feasibility.
  • Design and drive frameworks for scaling artificial intelligence adoption across business units in alignment with measurable business outcomes.
  • Identify and prioritize high-value artificial intelligence use cases across the enterprise, balancing feasibility, risk, and impact.
  • Design and own frameworks for value tracking, including cost reduction, productivity gains, and revenue enablement tied to artificial intelligence initiatives.
  • Partner with business and technical leaders to accelerate the transition from pilots to enterprise-scale deployment.
  • Craft board-ready narratives translating complex artificial intelligence strategies, technical architectures, and innovation pipelines into outcome-oriented stories for C-suite and board audiences.
  • Develop and maintain executive communication assets, including strategy briefs, roadmap visualizations, value-realization dashboards, and investment narratives.
  • Serve as a storytelling partner to Enterprise AI leadership, framing artificial intelligence initiatives in terms of business transformation, member outcomes, and competitive differentiation.
  • Distill technical complexity into simple frameworks that enable non-technical executives to make informed decisions on artificial intelligence investments and priorities.
  • Serve as a senior advisor on buy-versus-build-versus-partner strategies, model architecture and tooling choices, platform investments, and vendor selection.
  • Provide data-driven recommendations grounded in industry best practices and emerging trends.
  • Contribute to governance forums such as artificial intelligence review boards with deep technical insight and an independent perspective.
  • Partner with governance and risk functions to advance responsible artificial intelligence practices, including fairness, explainability, and compliance.
  • Provide technical input into model risk management frameworks, evaluation standards, and monitoring approaches.
  • Define and champion guardrails for safe and ethical scaling of generative artificial intelligence capabilities.
  • Act as a trusted advisor to senior executives, translating highly technical artificial intelligence concepts into clear business implications.
  • Influence roadmaps across Enterprise AI, Cloud, Data, and Security teams without direct ownership.
  • Continuously scan and synthesize the external artificial intelligence landscape, including emerging models, tooling, competitive moves, regulatory developments, and academic research, and translate insights into actionable recommendations.
  • Establish a structured mechanism such as quarterly trend briefings or competitive intelligence digests for bringing outside-in perspectives to Enterprise AI leadership and key stakeholders.
  • Build and leverage an external network of artificial intelligence practitioners, researchers, and industry analysts.
  • Represent the organization in selective external forums as a thought leader in enterprise artificial intelligence strategy and adoption.

Humana focuses on health and well-being by offering Medicare Advantage plans (HMO, PPO, and PFFS) mainly for seniors, military personnel, and communities. Its products are health insurance plans funded through a mix of government contracts and member premiums, enrolling members to provide comprehensive coverage with flexible benefits and a broad provider network. Members receive care through a network of providers, with additional services such as free language interpretation to improve accessibility. Humana differentiates itself through its emphasis on inclusivity, accessibility, and tailored benefits, aiming to deliver reliable service and high renewal rates. The goal is to improve health outcomes and overall well-being for members by delivering coverage that meets diverse needs and making care accessible to all.

Company Size

10,001+

Company Stage

IPO

Headquarters

Louisville, Kentucky

Founded

1961

Get referred to Humana

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Second-quarter 2026 revenue reached $40.87 billion, up 26.2%, beating estimates.
  • Illinois awarded Humana a statewide Medicaid contract starting January 2027, broadening state footing.
  • Humana expects 2027 MA membership growth of roughly 25%, despite plan exits.

What critics are saying

  • CMS star-rating losses cut 2026 GAAP EPS guidance to at least $6.52.
  • 2027 plan exits hit 600,000 members, risking churn and weaker brand trust.
  • Texas appeal loss or further CMS downgrades can erase billions in MA bonuses.

What makes Humana unique

  • Humana leads Medicare Advantage with 6.45 million individual MA members in 2026.
  • CenterWell and Medicaid expansion add care delivery and government-contract diversification beyond insurance.
  • August 2026 board adds Anthropic's Paul Smith, signaling faster AI-enabled care operations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Unlimited Paid Time Off

Paid Vacation

Paid Parental Leave

Short-term Disability

Long-term Disability

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

6%
PR Newswire
Sep 2nd, 2026
Thyme Care raises $125M at $2B+ valuation to expand oncology care model

Thyme Care, a Nashville-based oncology company, has closed a Series E funding round of more than $125 million at a valuation exceeding $2 billion. Morgan Health led the round, with participation from CVS Health Ventures, Humana, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health. The company now serves over 10.5 million people across all 50 US states and manages more than $7 billion in oncology spend. Thyme Care reports it is profitable with positive free cash flow whilst delivering validated reductions of 5 to 10 per cent in total cost of care. Alongside the funding, Thyme Care is establishing Thyme Companies, a parent entity that will build a portfolio of independent oncology businesses addressing care barriers. Co-founder Robin Shah will serve as executive chairman of the new entity.

Associated Press
Aug 20th, 2026
Humana appoints Dr. Shantanu Nundy as chief medical officer to lead AI and digital care strategy

Humana has appointed Dr Shantanu Nundy as Chief Medical Officer, effective 31 August. Dr Nundy, a practicing physician and healthcare executive, will help shape the company's products, platforms, and use of AI whilst bringing clinical expertise to the enterprise. He most recently served as Executive Vice President of Care Delivery and Chief Health Officer at Accolade, a healthcare navigation company. Previously, he was Managing Director for Clinical Innovation at Evolent Health, driving value-based and digital care transformation across health systems. Dr Nundy will report to Jim Rechtin, Humana's President and CEO, and join the company's Enterprise Leadership Team. He continues to practice primary care and hospital medicine.

Yahoo Finance
Aug 19th, 2026
Humana beats Q2 revenue estimates with $40.87B as health insurers face regulatory scrutiny

Humana reported Q2 revenues of $40.87 billion, up 26.2% year on year, exceeding analysts' expectations by 0.6%. The health insurance provider also beat earnings per share estimates. Despite the relatively strong results, Humana's stock has fallen 2.7% since the earnings announcement and currently trades at $378.11. The health insurance sector as a whole showed resilience in Q2, with the 12 tracked providers beating revenue consensus estimates by 2.8% on average. However, share prices across the sector have declined an average of 5.8% since reporting. Humana derives over 80% of its revenue from federal government contracts and serves approximately 17 million members, with a strong focus on Medicare Advantage plans for seniors.

Yahoo Finance
Aug 17th, 2026
Health insurers drop Medicare Advantage plans affecting nearly 3M older Americans

Nearly 3 million older Americans will lose their Medicare Advantage plans this year, according to Johns Hopkins Bloomberg School of Public Health research. One in 10 Medicare Advantage policyholders face forced disenrollment, with Vermont hit hardest at 92% of policyholders affected. Humana announced its exit from multiple markets for the second consecutive year, impacting 600,000 members. The company reported $1.9 billion profit in the first half of 2026. Insurers cite financial pressures from federal policy changes aimed at reducing overpayments, resulting in lower government reimbursement rates. Combined with rising medical costs, these factors are squeezing profit margins. Shannon Benton of Senior Citizens League said Humana's decision shows Medicare Advantage insurers are "prioritising profit growth over enrollment growth.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.